Accordingly, we evaluated anti-tumour efficacy in immune-competent transgenic mice, tolerant to human ERBB2, harbouring ectopic, established tumours based on ERBB2-positive LLC1 murine cancer cells27. The gene discussed is ERBB2; the disease is cancer.